Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-19 Purchase | 2023-12-19 6:39 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 30,000 | $1.37 | $41,100 | 697,761 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-14 4:24 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 22,950 | $0.98 | $22,491 | 667,761 (Direct) | View |
| 2022-11-25 Purchase | 2022-11-29 4:11 pm | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 10,000 | $1.43 | $14,300 | 24,481 (Direct) | View |
| 2022-09-16 Purchase | 2022-10-11 4:22 pm | Cardiff Oncology Inc. | CRDF | Armitage James O Director | 13,000 | $1.5564 | $20,233 | 13,000 (Indirect) | View |
| 2022-09-19 Purchase | 2022-09-20 6:08 pm | Cardiff Oncology Inc. | CRDF | White Lale Director | 15,000 | $1.635 | $24,525 | 113,788 (Indirect) | View |
| 2022-09-15 Purchase | 2022-09-19 08:37 am | Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director | 10,000 | $1.7168 | $17,168 | 10,000 (Direct) | View |
| 2022-09-15 Purchase | 2022-09-19 08:37 am | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 150,000 | $1.71 | $256,500 | 644,811 (Direct) | View |
| 2022-09-16 Purchase | 2022-09-19 08:37 am | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 30,000 | $1.557 | $46,710 | 60,000 (Direct) | View |
| 2021-09-21 Purchase | 2021-09-22 5:54 pm | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 30,000 | $6.75 | $202,500 | 494,811 (Direct) | View |
| 2021-09-10 Purchase | 2021-09-13 08:12 am | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 30,000 | $6.4667 | $194,000 | 30,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-07 6:40 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 205,008 | $0 | 962,496 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 6:40 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Kabbinavar Fairooz Chief Medical Officer | 205,008 | $0 | 630,008 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 6:39 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Smeal Tod Chief Scientific Officer | 205,008 | $0 | 647,184 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-07 6:39 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 510,000 | $0 | 2,170,310 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:08 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | Markin Rodney S Director | 27,700 | $0 | 152,327 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:06 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | Armitage James O Director | 27,700 | $0 | 117,274 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:05 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | White Lale Director | 27,700 | $0 | 117,274 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:04 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 27,700 | $0 | 117,274 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:03 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | Mohindru Mani Director | 27,700 | $0 | 98,501 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:02 pm | 2024-06-15 2033-06-15 | Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director | 27,700 | $0 | 98,501 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:42 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Smeal Tod Chief Scientific Officer | 167,088 | $0 | 442,176 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:42 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 197,472 | $0 | 757,488 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:41 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO | 125,520 | $0 | 698,304 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:41 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 482,064 | $0 | 1,664,477 (Direct) | View |
Ownership | 2023-02-09 4:50 pm | N/A 2033-01-30 | Cardiff Oncology Inc. | CRDF | Kabbinavar Fairooz Chief Medical Officer | 0 | $0 | 425,000 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-06 4:10 pm | 2021-06-17 2030-06-17 | Cardiff Oncology Inc. | CRDF | White Lale Director | 28,858 | $2.6 | 159,504 (Direct) | View |
| 2022-06-09 Other | 2022-06-09 7:48 pm | 2022-06-09 2024-06-09 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Former Director Director | 124,318 | $0 | 1,127,853 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 2:11 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | PACE GARY W Director | 26,800 | $0 | 89,574 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:43 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | White Lale Director | 26,800 | $0 | 89,574 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:43 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | TANNENBAUM RENEE P Director | 26,800 | $0 | 70,801 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:42 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Ruffner Katherine L Chief Medical Officer | 170,016 | $0 | 370,016 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:42 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | Mohindru Mani Director | 26,800 | $0 | 70,801 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:41 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | Markin Rodney S Director | 26,800 | $0 | 124,627 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:40 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Levine James E. Chief Financial Officer | 170,016 | $0 | 560,016 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:40 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Kelemen Vicki Exec. VP and COO | 170,016 | $0 | 572,784 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:39 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 370,128 | $0 | 1,185,400 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:38 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 26,800 | $0 | 125,317 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:38 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | Armitage James O Director | 26,800 | $0 | 89,574 (Direct) | View |
Ownership | 2022-01-14 1:34 pm | N/A 2032-01-10 | Cardiff Oncology Inc. | CRDF | Smeal Tod Chief Scientific Officer | 0 | $0 | 275,088 (Direct) | View |
| 2021-07-12 Option Award | 2021-07-14 4:00 pm | N/A 2031-07-12 | Cardiff Oncology Inc. | CRDF | Ruffner Katherine L Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |